Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)
China flag China · Delayed Price · Currency is CNY
8.93
-0.12 (-1.33%)
May 20, 2026, 2:25 PM CST

SHE:300016 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
429.29295.44257.46748.45766.73895.02
Trading Asset Securities
371.13379.75350.77---
Cash & Short-Term Investments
800.42675.18608.23748.45766.73895.02
Cash Growth
-4.07%11.01%-18.73%-2.38%-14.33%-11.71%
Accounts Receivable
238.25265.25176.36188.55112.67142.52
Other Receivables
0.848.079.545.878.395.81
Receivables
239.09273.32185.9194.42121.06148.33
Inventory
355.93383.75362.09244.86276.22250.01
Other Current Assets
51.5744.5614.959.071412.72
Total Current Assets
1,4471,3771,1711,1971,1781,306
Property, Plant & Equipment
1,1401,125976.03876.23840.46795.3
Long-Term Investments
184.46578.74536.76556.06561.19553.2
Goodwill
46.9246.9246.92-31.8251.23
Other Intangible Assets
143.72147.22160.82128.39125.1138.99
Long-Term Accounts Receivable
1.321.311.43---
Long-Term Deferred Tax Assets
35.623741.3341.3839.3218.15
Long-Term Deferred Charges
25.1225.2724.9417.236.9532.4
Other Long-Term Assets
415.369.3118.113.385.838.92
Total Assets
3,4393,3482,9782,8192,8192,904
Accounts Payable
196.31214.38171.32115.12140.9141.13
Accrued Expenses
14.6555.0844.534.8932.0526.06
Short-Term Debt
283.6216.96140.02175.56107.6179.08
Current Portion of Long-Term Debt
23.4537.554912.410.0920.13
Current Portion of Leases
-0.923.263.042.740.27
Current Income Taxes Payable
18.767.84---0.01
Current Unearned Revenue
6.326.668.762.014.453.8
Other Current Liabilities
61.8235.0138.3816.144.8315.09
Total Current Liabilities
604.9574.39455.23359.17302.67285.56
Long-Term Debt
265.89248.79600.24592.55516.28476.1
Long-Term Leases
1.752.164.87.179.980.14
Long-Term Unearned Revenue
22.324.5216.8411.747.8910.45
Long-Term Deferred Tax Liabilities
80.1480.570.9362.4858.5645.98
Total Liabilities
974.97930.361,1481,033895.39818.22
Common Stock
562.87562.87491.95491.93491.96492.72
Additional Paid-In Capital
697.91697.91135.34135.22135.3201.27
Retained Earnings
1,040994.58926.45912.791,0191,042
Treasury Stock
-----0.1-9.06
Comprehensive Income & Other
4.023.36113.86110.67130.27130.04
Total Common Equity
2,3042,2591,6681,6511,7761,857
Minority Interest
159.93158.45161.9135.69146.88229.03
Shareholders' Equity
2,4642,4171,8291,7861,9232,086
Total Liabilities & Equity
3,4393,3482,9782,8192,8192,904
Total Debt
574.69506.37797.32790.72646.71575.72
Net Cash (Debt)
225.73168.81-189.09-42.28120.03319.31
Net Cash Growth
-----62.41%2.79%
Net Cash Per Share
0.420.33-0.42-0.090.210.66
Filing Date Shares Outstanding
562.87562.87491.95491.93491.96492.72
Total Common Shares Outstanding
562.87562.87491.95491.93491.96492.72
Working Capital
842.1802.42715.95837.62875.341,021
Book Value Per Share
4.094.013.393.363.613.77
Tangible Book Value
2,1142,0651,4601,5221,6191,667
Tangible Book Value Per Share
3.763.672.973.093.293.38
Buildings
-699.61700.49561.7557.21532.04
Machinery
-609.14567.37503.01470.31400.02
Construction In Progress
-260.8770.26110.3944.9949
Source: S&P Global Market Intelligence. Standard template. Financial Sources.